Funding Rounds
Haya Therapeutics

Haya Therapeutics Series D Round, September 2024

Haya Therapeutics

RNA-guided regulatory genome targeting therapeutics developer for chronic diseases.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series D

Raised Amount: $1000.00M

Raised Date: 2024-09-04